SMT bio Co., Ltd.   Report issue

For profit Phase 2
Founded: Gyeongsan Korea, Republic of (2010)

Organization Overview

First Clinical Trial
2019
NCT03937895
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

SMT bio Co., Ltd.